Due to the insufficient protection observed in PD rats with severe lesions in the experiments, we then tested whether a joint delivery of CDNF and AADC, an enzyme which can convert levodopa to dopamine, could ameliorate the motor dysfunction in this advanced PD model. This evidence concerns the gene CDNF and Parkinson disease.